文献速递眼底病与葡萄膜炎

一种用于将局灶性黄斑解剖学变化与脉络膜毛细血管灌注局灶性变化相关联的新型网格策略

A Novel Grid Strategy for Correlating Focal Macular Anatomic Changes With Focal Changes in Choriocapillaris Perfusion.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

本研究基于扫频源光学相干断层扫描血管成像,建立黄斑网格内脉络膜毛细血管血流缺损(CCFD)测量的重复性,并验证该配准网格策略用于纵向随访CCFD测量。研究纳入63例患者共90只眼(正常30只、iAMD 30只、hyperTD 30只),计算各区域CCFD%的95%最小可检测变化(MDC95),并在玻璃膜疣消退前后进行纵向网格分析,未观察到CCFD%的显著差异。

要点

  • 在3 mm和5 mm黄斑中心圆内,正常、iAMD和hyperTD眼的CCFD%的MDC95范围为0.85%至1.96%。
  • 单个网格框的MDC95范围为3.35%至4.67%,总网格区域的MDC95范围为0.91%至1.40%。
  • 使用网格策略在玻璃膜疣消退前后进行纵向检测,未观察到CCFD%的显著差异。

核心结论

  • 开发了一种网格策略用于研究CCFD%与OCT生物标志物变化相关的靶向纵向变化,并使用玻璃膜疣消退眼对该策略进行了验证。

研究设计与样本

  • 获取标称6×6 mm的扫频源光学相干断层扫描血管成像扫描,生成高反射灶、钙化玻璃膜疣和持续性脉络膜高透射缺陷(hyperTDs)掩膜,在计算CCFD%时排除这些预设区域。

主要发现

  • 共识别63例患者的90只眼:正常眼30只、中间型年龄相关性黄斑变性(iAMD)眼30只、hyperTD眼30只。
  • 正常、iAMD和hyperTD眼在3 mm和5 mm圆内的CCFD%的MDC95范围为0.85%至1.96%。
  • 单个网格框的CCFD%的MDC95范围为3.35%至4.67%,总网格区域的MDC95范围为0.91%至1.40%。
  • 使用网格策略在玻璃膜疣消退前后进行纵向检测,未观察到CCFD%的显著差异。

关键数值与推荐

  • 在3 mm和5 mm黄斑中心圆内,正常、iAMD和hyperTD眼的CCFD%的MDC95范围为0.85%至1.96%。
  • 单个网格框(74×74像素)的CCFD%的MDC95范围为3.35%至4.67%。
  • 总网格区域的CCFD%的MDC95范围为0.91%至1.40%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To establish the repeatability of choriocapillaris flow deficit (CCFD) measurements within a macular grid and then demonstrate the use of this registered grid strategy to follow CCFD measurements over time. METHODS: Swept-source optical coherence tomography angiography scans were acquired (nominal size of 6 × 6 mm). For each scan, masks of hyperreflective foci, calcified drusen, and persistent choroidal hypertransmission defects (hyperTDs) were generated. These masks were then used to exclude these prespecified regions when calculating the CCFD percentages (CCFD%). Scans were registered, and CCFD% measurements were performed within 3-mm and 5-mm fovea-centered circles and within a fovea-centered grid (one box: 74 × 74 pixels). The 95% minimal detectable changes (MDC95) for CCFD% were calculated for each of the regions. This longitudinal grid workflow was then used to study eyes before and after drusen resolved. RESULTS: Ninety eyes of 63 patients were identified: 30 normal eyes, 30 eyes with intermediate age-related macular degeneration (iAMD), and 30 eyes with hyperTDs. The MDC95 for the normal, iAMD, and hyperTD eyes within the 3-mm and 5-mm circles ranged from 0.85% to 1.96%. The MDC95 for an individual grid's box ranged from 3.35% to 4.67%, and for the total grid area, the MDC95 ranged from 0.91% to 1.40%. When tested longitudinally before and after the resolution of drusen using grid strategy, no significant differences in the CCFD% were observed. CONCLUSIONS: A grid strategy was developed to investigate targeted longitudinal changes in CCFD% associated with changes in optical coherence tomography biomarkers, and this strategy was validated using eyes in which drusen resolved.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Hiya FE, Cheng Y, Shen M, et al. A Novel Grid Strategy for Correlating Focal Macular Anatomic Changes With Focal Changes in Choriocapillaris Perfusion. Invest Ophthalmol Vis Sci. 2024. PMID: 39625442. doi:10.1167/iovs.65.14.5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。